Corient Private Wealth’s NanoViricides NNVC Stock Holding History
Bought
Maintained
Sold
Other funds holding NNVC
Corient Private Wealth's NNVC Position: Q3 2026 in Review
Corient Private Wealth opened a new position in NanoViricides (NNVC) in Q3 2026: 17,512 shares worth $22.8K. The stake represents ﹤0.01% of the portfolio and ranks #3242 among its holdings.
50 funds tracked by Wall St. Rank hold NNVC as of Q3 2026.
- Corient Private Wealth held 17,512 shares of NanoViricides worth $22.8K as of Q3 2026.
- NanoViricides was a new Corient Private Wealth position in Q3 2026.
- NanoViricides made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #3242 holding.
- 50 funds tracked by Wall St. Rank held NanoViricides as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.